Ophthalmic Genetics and Gene Therapy

Gene therapy is an exploratory technique that employs genes to treat or prevent diseases. In near future, this technique may include a doctor replacing the mutated gene with a healthy copy of the gene to the patient in order to cure the abnormalities instead of surgery or drugs. Ophthalmic genetics is a branch of ophthalmology which refers to the field where the genetic background of disease is researched. Liber Congenital Amaris (LCA) is a hereditary genetic disease that causes childhood blindness. Scientists and doctors have treated this disease with the help of gene therapy.

 

  • Genetics of myopia development
  • Gene therapy
  • Usher syndrome
  • Familial exudative vitreal retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy

Related Conference of Ophthalmic Genetics and Gene Therapy

April 20-21, 2023

8th International Conference on Eye and Vision

Paris, France
May 17-18, 2023

23rd Global Ophthalmologists Annual Meeting

Prague, Czech Republic
May 24-25, 2023

3rd International Conference on Optics & Photonics

Montreal, Canada
May 31-01, 2023

9th Global Ophthalmology Meeting

Rome, Italy
July 26-27, 2023

17th International Conference on Hepatology

Singapore City, Singapore
July 31-01, 2023

37th European Ophthalmology Congress

Vancouver, Canada
August 28-29, 2023

22nd Asia Pacific Ophthalmologists Annual Meeting

Singapore City, Singapore
September 18-19, 2023

33rd International Congress on Vision Science and Eye

Rome, Italy
October 02-03, 2023

33rd World Congress on Ophthalmology and Optometry

Paris, France
October 09-10, 2023

4th International Conference on Optometry

Prague, Czech Republic
November 06-07, 2023

7th World Congress on Eye and Vision

Stockholm, Sweden

Ophthalmic Genetics and Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in